Recurrent genetic defects on chromosome 7q in myeloid neoplasms-Reference-Cited by-同舟云学术

Recurrent genetic defects on chromosome 7q in myeloid neoplasms

Published:2014-01-16 Issue:6 Volume:28 Page:1348-1351
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Hosono N,Makishima H,Jerez A,Yoshida K,Przychodzen B,McMahon S,Shiraishi Y,Chiba K,Tanaka H,Miyano S,Sanada M,Gómez-Seguí I,Verma A K,McDevitt M A,Sekeres M A,Ogawa S,Maciejewski J P

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201425.pdf

Reference15 articles.

1. Ernst T, Chase AJ, Score J, Hidalgo-Curtis CE, Bryant C, Jones AV et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat Genet 2010; 42: 722–726.

2. Makishima H, Jankowska AM, Tiu RV, Szpurka H, Sugimoto Y, Hu Z et al. Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Leukemia 2010; 24: 1799–1804.

3. Nikoloski G, Langemeijer SM, Kuiper RP, Knops R, Massop M, Tonnissen ER et al. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat Genet 2010; 42: 665–667.

4. Jerez A, Sugimoto Y, Makishima H, Verma A, Jankowska AM, Przychodzen B et al. Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis. Blood 119: 6109–6117.

5. Gomez-Segui I, Makishima H, Jerez A, Yoshida K, Przychodzen B, Miyano S et al. Novel recurrent mutations in the RAS-LIKE GTP-Binding gene RIT1 in myeloid malignancies. Leukemia 2013; 27: 1943–1946.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kmt2c restricts G-CSF-driven HSC mobilization and granulocyte production in a methyltransferase-independent manner;Cell Reports;2024-08

2. Biological relevance of alternative splicing in hematologic malignancies;Molecular Medicine;2024-05-17

3. Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets;Leukemia;2023-08-26

4. Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromes;Modern Pathology;2022-09

5. Clinical Application of Biomarkers for Hematologic Malignancies;Biomarkers in Medicine;2022-08-30